To further investigate this process, we quantified the fraction of tumor cells that either showed endothelial VE-cadherin at the cell-cell contacts, or had disrupted the homophilic VE-cadherin contacts between HUVEC endothelial cells. This evidence concerns the gene CDH5 and neoplasm.